ARCUS BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.55 USD | +5.57% |
|
+6.58% | -18.59% |
Chart calendar Arcus Biosciences, Inc.
eb1d21434ab0a8.zWTcYWZI5KEfChUyQtoI0GpXXJdPa5wlh2RiB_1VUXQ._1KeJSgbqMlTfmEBG5trvTllLOI7I6putiJVP6UKYQGiLp8MMwCn-0o5eg~5635ca61d07fbf40b24c5991cf70dcef
Upcoming events on Arcus Biosciences, Inc.
Past events on Arcus Biosciences, Inc.
| 12/03/2024 18:35 | Barclays Global Healthcare Conference |
| 11/03/2024 20:00 | Leerink Partners Global Biopharma Conference - Fireside Chat |
| 22/02/2024 19:00 | Citi Oncology Leadership Virtual Summit |
| 21/02/2024 22:00 | Q4 2023 Earnings Call |
| 20/02/2024 | Q4 2023 Earnings Release After hours |
| 19/01/2024 20:30 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium |
| 28/11/2023 12:55 | Evercore ISI HealthCONx Conference |
| 07/11/2023 22:00 | Q3 2023 Earnings Call |
| 07/11/2023 21:01 | Q3 2023 Earnings Release |
| 26/09/2023 15:30 | Cantor Global Healthcare Conference - Fireside Chat |
| 12/09/2023 21:15 | Morgan Stanley Global Healthcare Conference - Fireside Chat |
| 06/09/2023 20:30 | Citi BioPharma Conference - Panel |
| 06/09/2023 15:15 | Wells Fargo Healthcare Conference - Fireside Chat |
| 07/08/2023 13:00 | Q2 2023 Earnings Release |
| 15/06/2023 16:30 | Annual General Meeting |
| 14/06/2023 00:00 | Goldman Sachs Global Healthcare Conference |
| 04/06/2023 14:00 | American Society of Clinical Oncology Conference - Abstract No : TPS4602 |
| 04/06/2023 14:00 | American Society of Clinical Oncology Conference - Abstract No : TPS4206 |
| 04/06/2023 14:00 | American Society of Clinical Oncology Conference - Abstract No : TPS9141 |
| 04/06/2023 14:00 | American Society of Clinical Oncology Conference - Abstract No : TPS8609 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 15,0 6,72 123.32% | 77,5 76,0 2.04% | 383 185 106.59% | 112 104 8.01% | 117 114 2.93% | 189 |
|
EBITDA Million USD | Released Forecast Spread | -85,1 -92,9 8.32% | -121 -126 3.84% | 58,1 -83,3 169.71% | -274 -255 -7.51% | -332 -307 -8% | -277 |
|
EBIT Million USD | Released Forecast Spread | -88,7 -93,9 5.51% | -124 -121 -2.79% | 54,2 -243 122.37% | -280 -277 -1.16% | -340 -325 -4.5% | -322 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -84,7 -91,4 7.36% | -123 -119 -2.89% | 54,6 -242 122.61% | -266 -279 4.55% | -301 -298 -0.89% | -338 |
|
Net income Million USD | Released Forecast Spread | -84,7 -90,6 6.54% | -123 -119 -2.88% | 52,8 -242 121.86% | -267 -276 3.29% | -307 -300 -2.46% | -325 |
|
EPS USD | Released Forecast Spread | -1,93 -2,14 9.67% | -2,24 -2,15 -3.98% | 0,71 -3,53 120.09% | -3,71 -3,84 3.48% | -4,15 -4,05 -2.41% | -3,85 |
| Announcement Date | 05/03/20 | 24/02/21 | 23/02/22 | 28/02/23 | 21/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 354 49,4 617.13% | 18,0 27,2 -33.84% | 26,8 21,6 24.05% | 33,6 22,2 51.56% | 34,0 23,7 43.34% | 25,0 22,5 11.27% | 29,0 31,8 -8.84% | 32,0 27,6 16.12% | 31,0 28,3 9.54% | 29,2 | 30,5 | 30,6 | 30,7 | 27,4 |
|
EBITDA Million USD | Released Forecast Spread | -72,5 -60,3 -20.34% | -88,0 -86,9 -1.28% | -87,2 | -88,1 | -89,1 | |||||||||
|
EBIT Million USD | Released Forecast Spread | 281 -40,4 795.82% | -67,2 -61,1 -10.02% | -69,0 -67,3 -2.44% | -69,4 -52,0 -33.58% | -74,0 -81,4 9.04% | -86,0 -87,7 1.98% | -83,0 -87,1 4.75% | -80,0 -86,0 6.99% | -91,0 -84,2 -8.02% | -89,2 | -90,6 | -92,9 | -93,8 | -92,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 281 -76,5 467.53% | -67,0 -64,1 -4.54% | -66,6 -66,6 -0.01% | -64,9 -78,4 17.21% | -67,0 -84,5 20.75% | -78,0 -90,3 13.6% | -74,0 -83,6 11.45% | -69,0 -83,7 17.61% | -80,0 -76,0 -5.3% | -84,6 | -84,9 | -88,2 | -90,7 | -92,0 |
|
Net income Million USD | Released Forecast Spread | 279 -76,5 465.16% | -68,0 -62,9 -8.09% | -66,6 -66,7 0.1% | -64,9 -77,4 16.09% | -67,0 -79,1 15.33% | -80,0 -86,5 7.5% | -75,0 -78,3 4.23% | -69,0 -82,5 16.41% | -81,0 -75,0 -8.04% | -84,8 | -85,1 | -88,4 | -90,9 | -92,0 |
|
EPS USD | Released Forecast Spread | 3,71 -0,62 701.62% | -0,96 -0,79 -21.01% | -0,93 -0,94 0.53% | -0,90 -1,07 15.55% | -0,93 -1,10 15.45% | -1,09 -1,19 8.11% | -1,04 -1,08 3.45% | -0,94 -1,13 16.44% | -1,08 -1,02 -6.27% | -0,97 | -0,96 | -0,99 | -1,02 | -1,05 |
| Announcement Date | 23/02/22 | 09/05/22 | 03/08/22 | 02/11/22 | 28/02/23 | 09/05/23 | 07/08/23 | 07/11/23 | 21/02/24 | - | - | - | - | - |
More events
Past sector events for Arcus Biosciences, Inc.
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RCUS Stock
- Calendar Arcus Biosciences, Inc.
